1453, 1411, 1352, 1288, 1240, 1174, 1109, 1031, 991, 914, 858,
815, 730.
400 MHz) [Partial NMR only] 10.82 (1H, N–H), 7.36 (d, 1H
J = 8.52 Hz, Ar–H), 7.29 (s, 1H, Ar–H), 6.99 (d, 1H, J = 7.5 Hz,
Ar–H), 6.82–6.78 (m, 2H, Ar–H), 6.75 (t, 1H, J = 7.5 Hz,
Ar–H), 6.68 (d, 1H, J = 8.0 Hz, Ar–H), 1.32 (s, 9 H, tert-butyl
CH3), 1.30 (s, 18 H, tert-butyl CH3); dC (CDCl3, 100 MHz)
172.37, 171.94, 170.03, 152.60, 151.00, 135.31, 134.75, 127.67,
122.07, 120.90, 120.18, 112.02, 111.18, 104.95, 81.54, 81.31,
69.69, 69.28, 67.42, 55.30, 55.11, 54.89, 52.39, 52.14, 27.51,
27.44; MS (MeCN, ES+) m/z Expected: 1043.6. Found: 1044.6
(M + H), 1066.7 (M + Na), 522.8 (M + 2H)/2; IR mmax/cm−1
3420, 2974, 2857, 1728, 1680, 1607, 1512, 1454, 1368, 1311,
1165, 1105, 1008, 852, 755, 598.
General synthesis of 1, 2, 11 and 12
Compound 7, (0.2815 g, 0.658 mmol) [or 8, (0.468 g, 0.828 mmol)
in the case of 2] and 1 equivalent of 9 [or 10 in the case of 11
and 12] was placed into a 50 mL single-neck RBF. To this was
added 1 equivalent of Cs2CO3 and 40 mL of dry MeCN. The
solution was kept under dry conditions in an argon atmosphere
and stirred at 72 ◦C for 72 h. The resulting mixture was cooled
to room temperature and filtered through Celite. In the case
of 1 and 2, MeCN was removed under vacuum and the crude
material dissolved in CHCl3 (40 mL). This was washed with
water (5 × 20 mL). The organic phase was separated dried over
MgSO4 and reduced to give the desired product in a relatively
pure state. (Yields ca. 70%). In the case of 11 and 12, MeCN
was removed under vacuum to produce a crude oil. The crude
oil was dissolved in a small quantity of DCM and placed onto a
dry alumina column that was washed with DCM–THF (70 : 30)
which was slowly changed by gradient dilution to DCM–THF–
MeOH (60 : 30 : 10).
General synthesis of 3 and 4
The triester, 11 (or 12) (0.162 mmol) was placed into a 25 mL
single neck RBF. To this was added DCM (12 mL) and TFA
(5 mL). The solution was stirred for 24 h at room temperature.
The solvent was removed under reduced pressure and the acid
chased off by the addition and evaporation of successive portions
of DCM (2 × 10 mL), MeOH (2 × 10 mL) and diethyl ether
(2 × 10 mL). The resulting residue was dissolved into MeOH
(0.25 mL) to which ether (10 mL) was added dropwise yielding
the desired product as a solid. This was filtered off, washed with
cold ether and dried under vacuum. Both gave yields of >80%.
N-{3-Methoxy-4-[13-(2-methoxyphenyl)-1,4,10-trioxa-7,13-
diazacyclopentadec-7-yl]phenyl}-2-(4,7,10-tris(dimethylcarbamoyl)-
methyl-1,4,7,10-tetraazacyclododec-1-yl)acetamide (1). Com-
pound 1 was formed in ca. 77% yield. Calc. for C46H77N10O9:
[M + H] m/z = 913.5875. Found: 913.5858 (−1.9 ppm); dC
(CDCl3, 100 MHz) 170.30, 170.21, 170.07, 153.0, 152.6, 151.3,
140.16, 135.60, 125.29, 122.06, 121.30, 120.66, 120.50, 111.55,
104.25, 71.01, 70.89, 70.82, 70.51, 69.47, 55.17, 54.74, 54.36,
53.13, 52.92, 52.33, 52.21, 51.84, 36.82, 36.26, 35.23, 34.92; MS
(MeCN, ES+) m/z Expected: 912.5. Found: 913.5 (M + H),
456.9 (M + 2H)/2; IR mmax/cm−1 3420, 2937, 2855, 1647, 1510,
1451, 1403, 1260, 1238, 1217, 1108, 1030, 859, 810, 747, 629,
489.
[4,7-Bis(carboxymethyl)-10-({3-methoxy-4-[13-(2-methoxy-
phenyl)-1,4,10-trioxa-7,13-diazacyclopentadec-7-yl]phenylcar-
bamoyl}methyl)-1,4,7,10-tetraazacyclododec-1-yl]acetic
acid
(3). Compound 3 was formed in ca. 82% yield. Calc. for
C40H62N7O12: [M + H peak] m/z = 832.4456. Found: 832.4462
(+0.6 ppm); dH (CD3CN, 400 MHz) 10.88 (br s, 1H), 8.41 (br s,
1H), 7.57 (br s, 2H, Ar–H), 7.51 (s, 1H, Ar–H), 7.38–7.36 (m,
2H, Ar–H), 7.12–7.10 (m, 1H, Ar–H), 7.04 (s, 1H, Ar–H), 3.84
(br s, 6H), 3.61 (br s, 10H), 3.43–3.38 (m, 16H), 3.18 (br s, 20H);
MS (MeCN, ES+) m/z Expected: 831.44. Found: 832.3 (M +
H), 854.3 (M + Na), 416.6 (M + 2H)/2, 278.1 (M + 3H)/3; IR
mmax/cm−1 3429, 3104, 2958, 2924, 2854, 1683, 1504, 1461, 1375,
1355, 1203, 1181, 1127, 1104, 828, 801, 721, 689, 620, 598, 516.
N-{3-Methoxy-4-[16-(2-methoxyphenyl)-1,4,10,13-tetraoxa-
7,16-diazacyclooctadec-7-yl]phenyl}-2-(4,7,10-tris(dimethyl)-
carbamoylmethyl-1,4,7,10-tetraazacyclododec-1-yl)acetamide
(2). Compound 2 was formed in ca. 77% yield. Calc. for
C48H81N10O10: [M + H] m/z = 957.6137. Found: 957.6188
(+5.3 ppm); dC (CDCl3, 100 MHz) 170.28, 170.22, 170.07,
153.08, 152.80, 143.61, 138.80, 135.58, 125.27, 122.37, 121.63,
121.22, 120.47, 111.43, 104.16, 70.26, 69.54, 55.15, 54.78,
54.30, 52.93, 52.52, 52.42, 51.83, 36.82, 36.25, 35.22, 34.93; MS
(MeCN, ES+) m/z Expected: 956.6. Found: 957.6 (M + H),
979.0 (M + Na) 478.9 (M + 2H)/2; IR mmax/cm−1 3417, 2955,
2923, 2854, 1644, 1538, 1504, 1454, 1402, 1260, 1240, 1104,
1030, 812, 750.
[4,7-Bis(carboxymethyl)-10-({3-methoxy-4-[16-(2-methoxy-
phenyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-7-yl]phenylcar-
bamoyl}methyl)-1,4,7,10-tetraazacyclododec-1-yl]acetic
acid
(4). Compound 4 was formed in ca. 89% yield. Calc. for
C42H66N7O13: [M + H peak] m/z = 876.4719. Found: 876.4722
(+ 0.4 ppm); dH (CD3CN, 400 MHz) 10.88 (br s, 1H), 8.64
(br s, 1H), 7.59 (br s, 1H), 7.45 (br s, 1H), 7.27 (br s, 3H), 7.18
(s, 1H,), 7.07–7.01 (br m., 3H, Ar–H), 4.25–4.08 (br m., 4H,
Ar–H), 3.80 (br s, 9H), 3.48 (s, 27H), 3.15 (br s, 12H), 2.65 (br s,
2H); dC (CD3CN, 100 MHz) 173.18, 169.82, 169.43, 165.46,
154.50, 138.10, 126.41, 123.68, 121.12, 118.12, 115.26, 111.59,
102.99, 68.52, 66.62, 57.68, 56.36, 55.12, 54.45, 53.96, 53.36,
53.17, 52.84, 50.99, 49.33, 48.37, 46.80, 44.01; MS (MeCN,
ES+) m/z Expected: 875.4. Found: 876.5 (M + H), 898.5 (M +
Na), 439.1 (M + 2H)/2, 292.8 (M + 3H)/3; IR mmax/cm−1 3429,
3104, 2957, 2921, 2880, 1688, 1512, 1462, 1353, 1202, 1178,
1123, 1093, 827, 764, 719, 690, 618, 569, 513.
[4,7-Bis-tert-butoxycarbonylmethyl-10-({3-methoxy-4-[13-
(2-methoxyphenyl)-1,4,10-trioxa-7,13-diazacyclopentadec-7-
yl]phenylcarbamoyl}methyl)-1,4,7,10-tetraazacyclododec-1-yl]-
acetic acid tert-butyl ester (11). Compound 11 was formed
in ca. 57% yield. Calc. for C52H86N7O12: [M + H peak] m/z =
1000.6334. Found: 1000.6307 (−2.8 ppm); dC (CDCl3, 100 MHz)
172.58, 172.09, 170.18, 152.52, 151.20, 140.13, 135.48, 134.93,
122.05, 121.16, 120.64, 120.55, 112.27, 111.63, 105.35, 81.57,
81.52, 70.69, 70.41, 69.45, 67.63, 56.47, 55.50, 55.31, 55.08,
53.04, 52.72, 52.41, 52.22, 27.69, 27.62; MS (MeCN, ES+) m/z
Expected: 999.6. Found: 1000.6 (M + H), 1022.6 (M + Na),
500.7 (M + 2H)/2; IR mmax/cm−1 3428, 2975, 2854, 1728, 1681,
1607, 1504, 1454, 1368, 1312, 1228, 1166, 1106, 1008, 852, 756,
597.
General synthesis of Tb(III) complexes
Compounds 1 or 2 (∼100 mg, ∼0.1 mmol) and Ln(III) tri-
flouromethane sulfonate (0.1 mmol) were added to a 5 mL single
neck RBF that contained 3 mL of freshly dried MeCN. The
solution was freeze–pump–thawed three times, placed under
an argon atmosphere and left stirring at reflux for 24 h. The
resulting solution was cooled to room temperature and then
dropped slowly onto dry diethyl ether (50–70 mL). In the case of
Tb·1 and Tb·2 the diethyl ether was decanted to leave these
complexes in a crude state. These were dissolved in a small
quantity of DCM and placed onto dry alumina plugs that were
washed with DCM–THF (70 : 30) which was slowly changed
by gradient dilution to DCM–THF–MeOH (60 : 30 : 10) to
[4,7-Bis-tert-butoxycarbonylmethyl-10-({3-methoxy-4-[16-
(2-methoxyphenyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-
7-yl]phenylcarbamoyl}methyl)-1,4,7,10-tetraazacyclododec-1-
yl]acetic acid tert-butyl ester (12). Compound 12 was formed
in ca. 36% yield. Calc. for C54H90N7O13: [M + H peak]
m/z = 1044.6597. Found: 1044.6619 (+ 2.1 ppm); dH (CDCl3,
D a l t o n T r a n s . , 2 0 0 5 , 3 2 0 4 – 3 2 1 2
3 2 1 1